# OnCo record mangafodipir (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mangafodipir/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mangafodipir" ;
  schema:name "Mangafodipir (withdrawn liver MRI contrast)"@en ;
  schema:alternateName "mangafodipir"@en, "mangafodipir trisodium"@en, "Teslascan"@en, "Teslascan" ;
  schema:description "A liver MRI dye based on manganese that was authorised in Europe from 1997 to 2012 for finding liver metastases and liver cancer, and is no longer available."@en ;
  schema:url <https://onco.cc/drugs/mangafodipir/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/teslascan>, <https://atcddd.fhi.no/atc_ddd_index/?code=V08CA&showdescription=no> ;
  onco:status "withdrawn" ;
  onco:tag "contrast-agents-gaps-2026-11", "diagnostic" ;
  onco:modality "Manganese-based contrast agent for MRI of the liver and pancreas (intravenous, withdrawn)" ;
  onco:approval "EU 1997: MRI detection of liver lesions suspected to be metastases or hepatocellular carcinoma; adjunct for focal pancreatic lesions" ;
  onco:related <https://onco.cc/drugs/gadoxetate-disodium/> ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/gadolinium-based-contrast-agents/>, <https://onco.cc/technologies/mri/> ;
  onco:companies <https://onco.cc/companies/ge-healthcare/> .